跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ribomustin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ribomustin
Approved
STANDARD
Ribomustin
Oncotec Pharma Produktion GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6efee8382116a6a5
Company
Oncotec Pharma Produktion GmbH
Type
Standard
Approval Details
Approval Id
6efee8382116a6a5
Drug Approval Philippines Name
Ribomustin
Product Name
Ribomustin
Registration Number
DR-XY44831
Brand Name
Ribomustin
Generic Name
Bendamustine Hydrochloride
Dosage Form
Lyophilized Powder For Concentrate For Solution For IV Infusion
Dosage Strength
25 mg
Manufacturer
Oncotec Pharma Produktion GmbH
Importer
Johnson and Johnson (Phils.) Inc.
Distributor
Johnson and Johnson (Phils.) Inc.
Company Detail Path
/organization/oncotec-pharma-produktion-gmbh
Issuance Date
13 May 2022
Expiry Date
22 September 2025
Pharmacologic Category
Alkylating Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6efee8382116a6a5
Type
Standard
Back to Philippines FDA Approvals